Thrombosis and Haemostasis Archive: Schattauer GmbH Verlag für Medizin und Naturwissenschaften

home

Indicator

Free Access

No Access

Partial Access

2009: 102/3 (Sep) pp. 421-610

Journal:	Thrombosis and Haemostasis
ISSN:	0340-6245

Archive

Issue

28 articles

	21.	[Add to basket] Levels of von Willebrand factor antigen and von Willebrand factor cleaving protease (ADAMTS13) activity predict clinical events in chronic heart failure
		Tímea Gombos1; Veronika Makó1; László Cervenak1; Jana Papassotiriou2; Jan Kunde2; Jolán Hársfalvi3; Zsolt Förhécz1; Zoltán Pozsonyi1; Gábor Borgulya4; Lívia Jánoskuti1; Zoltán Prohászka4 1IIIrd Department of Internal Medicine, Semmelweis University, Budapest, Hungary; 2Department of Research, BRAHMS Aktiengesellschaft, Neuendorfstr. 25, D-16761 Hennigsdorf, Germany; 3Clinical Research Center, University of Debrecen, Debrecen, Hungary; 4Research Group of Inflammation Biology and Immunogenomics, Hungarian Academy of Sciences, Budapest, Hungary Thrombosis and Haemostasis 2009 102 3: 573-580 http://dx.doi.org/10.1160/TH09-01-0036
		[Summary] [PDF] [Pay per view]

	22.	[Add to basket] Red cell distribution width (RDW) as a predictor of long-term mortality in patients undergoing percutaneous coronary intervention
		Shyam Poludasu; Jonathan D. Marmur; Jeremy Weedon; Waqas Khan; Erdal Cavusoglu Division of Cardiology, Department of Medicine, and School of Public Health, State University of New York, Downstate Medical Center, New York, USA Thrombosis and Haemostasis 2009 102 3: 581-587 http://dx.doi.org/10.1160/TH09-02-0127
		[Summary] [PDF] [Pay per view]

	23.	[Add to basket] Variability of INR in patients on stable long-term treatment with phenprocoumon and acenocoumarol and implications for analytical quality requirements
		Johanna H. H. van Geest-Daalderop1; Nathalie C. V. Péquériaux1; Anton M. H. P. van den Besselaar2 1Thrombosis Service, Laboratory of Clinical Chemistry and Haematology, Jeroen Bosch Hospital, ‘s-Hertogenbosch, The Netherlands; 2Department of Thrombosis and Hemostasis, Leiden University Medical Center, Leiden, The Netherlands Thrombosis and Haemostasis 2009 102 3: 588-592 http://dx.doi.org/10.1160/TH09-02-0092
		[Summary] [PDF] [Pay per view]

	24.	[Add to basket] Internal quality control of prothrombin time in primary care: comparing the use of patient split samples with lyophilised control materials
		Anne Stavelin1; Per Hyltoft Petersen2; Una Sølvik2; Sverre Sandberg2,3 1NOKLUS, Norwegian Quality Improvement of Primary Care Laboratories, Haraldsplass Diaconal Hospital, Bergen, Norway; 2NOKLUS, Norwegian Quality Improvement of Primary Care Laboratories, Section for General Practice, Department of Public Health and Primary Health Care, University of Bergen, Bergen, Norway; 3Laboratory of Clinical Biochemistry, Haukeland University Hospital, Bergen, Norway Thrombosis and Haemostasis 2009 102 3: 593-600 http://dx.doi.org/10.1160/TH09-02-0082
		[Summary] [PDF] [Pay per view]

	25.	[Add to basket] Ovarian vein thrombosis in the first trimester of pregnancy
		Gerasimos Tzortzatos1; Angelos Sioutas1; Mats O. Beckman2 1Department of Obstetrics and Gynaecology, Karolinska University Hospital/Karolinska Institutet, Stockholm, Sweden; 2Department of Radiology, Karolinska University Hospital/Karolinska Institutet, Stockholm, Sweden. Thrombosis and Haemostasis 2009 102 3: 601-602 http://dx.doi.org/10.1160/TH09-03-0167
		[Summary] [PDF] [Pay per view]

	26.	[Add to basket] Analysis of the structural effects of four novel and a previously known mutations causing factor XI deficiency
		Silvia Spena1; Rosanna Asselta1; Sonia Caccia2; Valeria Rimoldi1; Sofia H. Giacomelli3; Annarita Tagliaferri4; Flora Peyvandi5; Giancarlo Castaman3; Stefano Duga1 1Dipartimento di Biologia e Genetica per le Scienze Mediche, Università degli Studi di Milano, Milano, Italia; 2Dipartimento di Scienze e Tecnologie Biomediche, Università degli Studi di Milano, Milano, Italia; 3Department of Hematology and Hemophilia Center, San Bortolo Hospital, Vicenza, Italy; 4Regional Reference Centre for Inherited Bleeding Disorders, University Hospital, Parma, Italy; 5Centro Emofilia e Trombosi A. Bianchi Bonomi, Dipartimento di Medicina Interna e Specialità Mediche, Fondazione IRCCS Ospedale Maggiore, Mangiagalli e Regina Elena, e Università degli Studi di Milano, Milano, Italia Thrombosis and Haemostasis 2009 102 3: 603-606 http://dx.doi.org/10.1160/TH09-02-0117
		[Summary] [PDF] [Pay per view]

	27.	[Add to basket] PPACK-Desmodus rotundus salivary plasminogen activator (cDSPAα1) prevents the passage of tissuetype plasminogen activator (rt-PA) across the blood-brain barrier and neurotoxicity
		Benoit D. Roussel1; Yannick Hommet1; Richard Macrez1; Torsten Schulz2; Karl-Uwe Petersen2; Vincent Berezowski3; Roméo Cecchelli3; Carine Ali1; Denis Vivien1 1INSERM, INSERM U919, Serine Proteases and Pathophysiology of the neurovascular Unit, CNRS, UMR CNRS 6232 CINAPs “Center for Imaging Neurosciences and Applications to Pathologies”, Cyceron, Caen Cedex, F-14074 France; University of Caen Basse-Normandie, Caen Cedex, France; 2PAION Deutschland GmbH, Aachen, Germany; 3Laboratoire de Physiopathologie de la Barrière Hémato-Encéphalique, EA 2465, IFR114-IMPRT, Université d’Artois, Faculté des Sciences Jean Perrin, France Thrombosis and Haemostasis 2009 102 3: 606-608 http://dx.doi.org/10.1160/TH09-02-0114
		[Summary] [PDF] [Pay per view]

	28.	[Add to basket] Species-dependent molecular drug targets in plasminogen activator inhibitor-1 (PAI-1)
		Ann Gils; Lester M. Meissenheimer; Griet Compernolle; Paul J. Declerck Laboratory for Pharmaceutical Biology, Faculty of Pharmaceutical Sciences, Katholieke Universiteit Leuven, Belgium Thrombosis and Haemostasis 2009 102 3: 609-610 http://dx.doi.org/10.1160/TH09-04-0257
		[Summary] [PDF] [Pay per view]